The Growing Problem of Mycoses in Patients Infected with the Human Immunodeficiency Virus
The DOI matches its Crossref record.
Abstract
With the rapid increase in cases of AIDS over the past 10 years, certain mycoses have dramatically risen in frequency, particularly those contained by T cell-mediated mechanisms of host defense. In this clinical setting mucocutaneous candidiasis as well as systemic cryptococcosis, histoplasmosis, and coccidioidomycosis pose special diagnostic and/or therapeutic challenges. Compared with fungal infections in general, AIDS-associated mycoses are more likely to have nonspecific clinical manifestations; moreover, treatments effective in other settings seldom are curative. These problems have led to new vigilance regarding mycoses in the differential diagnosis of complications of infection due to the human immunodeficiency virus (HIV) and have necessitated a redefinition of goals: the aim is now to suppress rather than cure infection in most cases. This change has stimulated trials of new antifungal agents and regimens particularly designed to facilitate long-term outpatient management of mycoses without interfering with treatment of either HIV infection itself or other concomitant complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ahmad, I., & Beg, A. Z. (2001) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00335-4 · Cited by 1,214
Fidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2012) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 505
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Rees, J. R., Pinner, R. W., Hajjeh, R. A., Brandt, M. E., & Reingold, A. L. (1998) · Clinical Infectious Diseases · doi:10.1093/clinids/27.5.1138 · Cited by 397
“The HIV disease epidemic has been shown to be responsible for dramatic increases in cryptococcal infections and esophageal candidiasis, and it has contributed to increases in cases of severe histoplasmosis and coccidioidomycosis [1-5].”
BackgroundCompounds active against cell walls of medically important fungi
Hector, R. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.1 · Cited by 242
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: Report of 33 cases
Lortholary, O., Meyohas, M.-C., Dupont, B., Cadranel, J., Salmon-Ceron, D., Peyramond, D., & Simonin, D. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90258-q · Cited by 199
“AIDS itself is not considered to be a full risk factor because the cellular defect mainly concerns T lymphocytes and less so neutrophils and macrophages, of which the latter two are involved in the defense against Aspergillus [3,4].”
BackgroundCurrent and future antifungal therapy: new targets for antifungal agents
Andriole, V. T. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.151 · Cited by 190
Vazquez, J. A., Peng, G., Sobel, J. D., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. O. A. (2001) · Clinical Infectious Diseases · doi:10.1086/322641 · Cited by 57
“Recurrence of oropharyngeal, esophageal, or vaginal candidiasis occurs in -60% of cases within 3 months [7].”
BackgroundVazquez, J. A., Sobel, J. D., Peng, G., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. I. A. (1999) · Clinical Infectious Diseases · doi:10.1086/514746 · Cited by 51
“perficial (mucosal) infections, produced by opportunistic fungal pathogens belonging to the Candida species [1-4].”
BackgroundRespiration, oxidative phosphorylation, and uncoupling protein in Candida albicans
Cavalheiro, R. A., Fortes, F., Borecký, J., Faustinoni, V. C., & Schreiber, A. Z. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004001000003 · Cited by 44
The in vitro interaction of Cryptococcus neoformans with human lung epithelial cells
Merkel, G. J., & Scofield, B. A. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(97)00085-0 · Cited by 4
Metadata
- Authors
- Diamond, R. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-05-01
- Volume
- 13
- Issue
- 3
- Pages
- 480-486
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2333694205
- Cited by
- 153
- References
- 0
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.